Skip to main content

Table 3 Summary of differential metabolites between OS and OSC

From: Untargeted LC–MS/MS analysis reveals metabolomics feature of osteosarcoma stem cell response to methotrexate

 

Metabolite

143B

MG63

VIP

P value

FC

VIP

P value

FC

Amino acid

Prolyl-Threonine

2.59

6.43 × 10−15

0.04

1.76

1.72 × 10−12

0.13

S-Methyl-5′-thioadenosine

2.23

3.60 × 10−05

1.21

3.38

5.45 × 10−12

2.44

S-Adenosyl-L-homocysteine

3.54

1.03 × 10−08

35.32

1.00

1.95 × 10−05

11.05

NAAG

1.06

5.40 × 10−07

1.61

1.42

1.92 × 10−08

7.63

Glutathione

12.13

1.11 × 10−14

16.90

5.25

2.69 × 10−08

10.60

Glutathione disulfide

1.04

1.21 × 10−4

1.13

1.70

1.07 × 10−05

1.80

L-Malic acid

2.71

7.98 × 10−10

8.12

1.73

3.57 × 10−09

1.53

N-Acetyl-l-aspartic acid

3.86

7.27 × 10−11

3.10

4.39

3.57 × 10−08

1.53

Harman

7.24

7.07 × 10−09

0.66

7.57

1.08 × 10−11

0.39

Indole-3-carboxylic acid

1.56

7.89 × 10−09

29.18

1.08

2.07 × 10−10

15.99

Fatty acids

Erucic acid

1.25

4.48 × 10−05

0.76

2.02

5.28 × 10−11

0.18

Erucamide

11.38

1.41 × 10−05

0.71

16.66

6.28 × 10−10

0.14

Linoleic acid

3.90

2.82 × 10−10

7.63

2.53

4.03 × 10−4

4.64

Stearic acid

3.78

1.54 × 10−07

0.63

3.89

2.15 × 10−10

0.48

Capric acid

2.57

4.40 × 10−09

0.62

1.77

2.32 × 10−08

0.66

Desmosterol

3.12

5.16 × 10−09

0.23

3.68

8.14 × 10−11

0.25

Undecanoic Acid

1.96

2.63 × 10−10

0.41

1.17

5.61 × 10−10

0.49

Stearoylcarnitine

6.89

2.06 × 10−12

0.19

9.86

2.68 × 10−11

0.33

LysoPE(16:0/0:0)

3.56

3.47 × 10−10

2.29

4.65

3.28 × 10−12

4.89

25-Hydroxycholesterol

3.23

1.12 × 10−08

0.21

2.24

1.51 × 10−09

0.15

LysoPE(18:0/0:0)

1.73

6.86 × 10−11

2.91

1.44

5.23 × 10−11

2.48

LysoPC(16:0)

13.45

2.66 × 10−10

1.80

14.17

1.02 × 10−12

3.12

LysoPC(O-18:0)

5.87

3.91 × 10−12

3.21

2.07

1.50 × 10−07

1.23

SOPC

3.60

6.80 × 10−3

0.63

4.52

2.21 × 10−13

0.28

Phosphorylcholine

1.58

1.63 × 10−09

0.25

2.97

2.93 × 10−13

0.07

16-Hydroxypalmitic acid

1.23

5.22 × 10−09

3.13

2.60

2.63 × 10−14

4.86

Oleic acid

1.53

4.42 × 10−05

1.72

2.49

4.40 × 10−07

2.26

LysoPE(16:0/0:0)

4.26

1.74 × 10−10

2.33

8.06

1.48 × 10−12

3.97

Retinol

2.72

1.05 × 10−14

10.70

1.83

1.85 × 10−12

8.09

Geranyl diphosphate

3.51

6.76 × 10−13

0.03

4.06

3.83 × 10−16

0.02

Carbohydrates

UDP-d-Glucose

3.23

7.36 × 10−09

4.24

2.32

7.16 × 10−05

2.24

d-Fructose 1,6-bisphosphate

3.38

1.98 × 10−06

0.13

1.35

1.08 × 10−07

0.49

Nucleic acid

2′-O-methylcytidine

3.92

1.37 × 10−11

0.26

4.05

4.73 × 10−14

0.11

Adenosine 3′-monophosphate

4.67

9.90 × 10−16

13.53

2.04

8.97 × 10−10

7.84

UDP

3.86

9.19 × 10−10

6.38

3.11

1.14 × 10−09

2.26

UTP

2.33

7.48 × 10−05

5.58

2.10

1.42 × 10−3

3.84

dGTP

9.72

1.21 × 10−05

2.47

5.47

1.90 × 10−2

1.32

  1. VIP Variable Importance for the Project, FC fold change, NAAG N-Acetylaspartylglutamate, SOPC 1-Stearoyl-2-oleoyl-sn-glycerol 3-phosphocholine, UDP-d-Glucose Uridine diphosphate glucose, UDP Uridine 5′-diphosphate, UTP Uridine 5′-triphosphate, dGTP deoxyguanosine triphosphate